T. Rowe Price Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-209,418	Closed	-$186K	–	2994
2022 Q4	$186K	Buy	209,418 +16,181	+8%	+$21.5K	﹤0.01%	2554
2022 Q3	$304K	Buy	193,237 +51,676	+37%	+$117K	﹤0.01%	2378
2022 Q2	$285K	Buy	141,561 +10,846	+8%	+$18.8K	﹤0.01%	2463
2022 Q1	$305K	Buy	130,715 +18,809	+17%	+$58.7K	﹤0.01%	2543
2021 Q4	$520K	Buy	111,906 +9,933	+10%	+$61.7K	﹤0.01%	2373
2021 Q3	$778K	Sell	101,973 -22,500	-18%	-$191K	﹤0.01%	2170
2021 Q2	$1.21M	Buy	124,473 +13,989	+13%	+$111K	﹤0.01%	1992
2021 Q1	$914K	Sell	110,484 -7,891	-7%	-$83.3K	﹤0.01%	2100
2020 Q4	$808K	Buy	118,375 +4,222	+4%	+$33.9K	﹤0.01%	2039
2020 Q3	$1.27M	Buy	114,153 +41,607	+57%	+$381K	﹤0.01%	1705
2020 Q2	$456K	Sell	72,546 -3,643	-5%	-$13.9K	﹤0.01%	2085
2020 Q1	$140K	Buy	76,189 +32,000	+72%	+$92.2K	﹤0.01%	2370
2019 Q4	$149K	Buy	44,189 +4,864	+12%	+$11.6K	﹤0.01%	2432
2019 Q3	$84K	Buy	39,325 +953	+2%	+$2.22K	﹤0.01%	2466
2019 Q2	$102K	Buy	38,372 +25,200	+191%	+$90.7K	﹤0.01%	2476
2019 Q1	$63K	Buy	13,172 +400	+3%	+$1.05K	﹤0.01%	2492
2018 Q4	$31K	Sell	12,772 -60,454	-83%	-$197K	﹤0.01%	2540
2018 Q3	$322K	Buy	73,226 +24,653	+51%	+$137K	﹤0.01%	2334
2018 Q2	$350K	Buy	48,573 +3,877	+9%	+$26.4K	﹤0.01%	2298
2018 Q1	$230K	Sell	44,696 -32,604	-42%	-$232K	﹤0.01%	2375
2017 Q4	$294K	Buy	+77,300	New	+$201K	﹤0.01%	2290
2015 Q4	–	Sell	-30,462	Closed	-$256K	–	2549
2015 Q3	$256K	Buy	+30,462	New	+$485K	﹤0.01%	2198